Abstract. The potential for inferring the presence of cancer by the detection of miRNA in human blood has motivated research into the design and operation of DNA-based chemical amplifiers that can operate in bodily fluids. As a first step toward this goal, we have tested the operation of a DNA-based autocatalytic network in human serum and mouse serum. With the addition of sodium dodecyl sulfate to prevent degradation by nuclease activity, the network was found to operate successfully with both DNA and RNA catalysts.
Introduction
Worldwide, approximately 1.3 million deaths per year are caused by lung cancer [1] . Early detection and diagnosis of cancer can lead to decreased mortality rates, yet current screening methods require significant resources [2] . Recently, microribonucleic acids (miRNAs) have been detected in human blood serum [3] . MicroRNAs are small, single-stranded, non-coding RNAs that are 21-23 nucleotides in length and regulate genes by suppression of messenger RNAs [4, 5] . Several miRNAs are amplified in various cancers [6] , and expression profiling reveals that miRNA signatures can be used for cancer classification and prognosis.
Current diagnosis technology requires reverse-transcription polymerase chain reaction (RT-PCR) to detect miRNAs in serum [7] . Developments in DNA computing have shown that it is possible to construct metastable DNA-based chemical networks that accept DNA as catalytic inputs and generate output DNA strands whose concentration increases exponentially to produce an easily detectable signal [8] . As miRNAs occur in blood in low abundance, such amplification networks would allow for detection without using PCR. In this study, we report the operation of the DNA-based autocatalytic network reported by Zhang et al. in human blood serum with sodium dodecyl sulfate (SDS). The autocatalytic DNA system accepts the input of either DNA or RNA catalysts and produces output signal strands that generate an easily detectable fluorescence signal.
Autocatalytic Network
To assess the feasibility of detecting miRNA in human serum using a DNA-based catalytic network, the entropy-driven autocatalytic system developed by Zhang et al. was selected as a test network. Figure 1(a) reproduces the autocatalytic network with the same domain naming convention [8] . In this network, strand 4 2bc is the autocatalyst that initiates signal strand production by toeholdmediated strand invasion of the substrate complex via the 2b domain. With an exposed3 domain, the fuel strand displaces two autocatalyst strands by two strand invasion processes and forms the waste complex. In each cycle, the amount of autocatalyst strand is doubled, leading to exponential growth of the signal strand. In Fig. 1(b) , the released signal strand reacts with a reporter complex to displace a tetrachlorofluorescein (TET) labeled strand. An increase in signal strand concentration is detected by an increase in the TET fluorescence intensity. Zhang et al. were able to demonstrate exponential behavior of this autocatalytic network in buffer and in a solution with total mouse liver RNA and rabbit reticulocyte lysate [8] , demonstrating successful operation in a complex biological environment. Zhang et al. [8] . In (a) the autocatalyst initiates the release of the signal strand. The fuel strand displaces both autocatalysts, producing the waste complex. Both released autocatalysts can then initiate new cycles. In (b) the reporter complex consists of a dye-quencher pair in the quenched state. The signal strand from (a) reacts with the reporter complex, displacing the TET dye labeled strand and producing an increase in fluorescence intensity.
